Seres Therapeutics Inc (NAS:MCRB)
$ 0.915 0.038 (4.33%) Market Cap: 156.22 Mil Enterprise Value: 176.53 Mil PE Ratio: 0 PB Ratio: 6.54 GF Score: 47/100

Q2 2019 Seres Therapeutics Inc Earnings Call Transcript

Aug 06, 2019 / 12:00PM GMT
Release Date Price: $2.29 (-6.15%)
Operator

Good day, ladies and gentlemen, and welcome to the Second Quarter 2019 Seres Therapeutics Earnings Conference Call.

(Operator Instructions)

As a reminder, this conference is being recorded. I would like to introduce your host for today's conference, Mr. Carlo Tanzi, Vice President, Investor Relations. Sir, please go ahead.

Carlo Tanzi
Seres Therapeutics, Inc. - VP of IR & Corporate Communications

Thank you, and good morning. Our press release with the company's second quarter 2019 financial results and a business update became available at 7 a.m. Eastern Time this morning and can be found on the Investors and Media section of the company's website.

I'd like to remind you that we'll be making forward-looking statements relating to the timing, enrollment and results of our clinical studies, regulatory matters, study designs, our development plans, our potential competitive advantages, the promise and potential impact of any of our microbiome therapeutics or clinical trial data and the sufficiency of our cash and cash equivalents

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot